{
    "clinical_study": {
        "@rank": "126234", 
        "arm_group": [
            {
                "arm_group_label": "Diet", 
                "arm_group_type": "Active Comparator", 
                "description": "The patients follow only a 1200 Kcal diet"
            }, 
            {
                "arm_group_label": "Diet +PENS dermatome T7", 
                "arm_group_type": "Experimental", 
                "description": "The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet"
            }
        ], 
        "brief_summary": {
            "textblock": "Percutaneous neurostimulation of dermatome T7 increases Insulin segregation by the apancreas\n      and improves glycemic profile in diabetic patients"
        }, 
        "brief_title": "Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Diabetes Mellitus Type 2 in Obese", 
            "Type 2 Diabetes Mellitus With Features of Insulin Resistance"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Insulin Resistance"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI>30 Kg/m2\n\n          -  Type 2 diabetes mellitus\n\n          -  Treatment with Metformin\n\n        Exclusion Criteria:\n\n          -  Under insulin treatment\n\n          -  Endocrinological disorders causing diabetes mellitus"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122874", 
            "org_study_id": "2014-003"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Diet", 
                    "Diet +PENS dermatome T7"
                ], 
                "description": "The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet", 
                "intervention_name": "Percutaneous Neurostimulation (PENS) of dermatome T7", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Diet", 
                "intervention_name": "1200 Kcal diet", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Percutaneous neurostimulation; dermatome T7, type 2 diabetes", 
        "lastchanged_date": "April 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Elche", 
                    "country": "Spain", 
                    "state": "Alicante", 
                    "zip": "03203"
                }, 
                "name": "General Hospital Elche"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Serum glucose levels will be recorded will be recorded at baseline and 12 weeks after beginning the treatment. Measurement units will be mg/dl.", 
            "measure": "Serum glucose levels (mg/dl)", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline and 12 weeks after beginning the therapy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122874"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital General Universitario Elche", 
            "investigator_full_name": "Jaime Ruiz-Tovar, MD, PhD", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Insulin resistance will be recorded by the Homeostasis model assessment (HOMA). The calculation formula is: Serum Glucose x Serum Insulin / 405", 
            "measure": "Homeostasis model assessment (HOMA)", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline and 12 weeks after beginning the therapy"
        }, 
        "source": "Hospital General Universitario Elche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital General Universitario Elche", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}